Dr. Reddy's Laboratories Ltd.

BSE

Price on BSE 22 Jan,12:00 LIVE

1,217.40

+61.90

(+5.36%)

Volume :
414,533.00

Prev Close :
1,155.50

Day's H/L (Rs.) :
1,224.25 - 1,188.95

52wk H/L (Rs.) :
1,377.95 - 1,025.90

Mkt Cap (Rs. Cr) :
101,604.21

NSE

Price on NSE 22 Jan,12:18 LIVE

1,223.40

+66.20

(+5.72%)

Volume :
4,085,647.00

Prev Close :
1,157.20

Day's H/L (Rs.) :
1,225.00 - 1,187.70

52wk H/L (Rs.) :
1,379.70 - 1,020.00

Mkt Cap (Rs. Cr) :
0.00

Market News

Domestic sales a booster dose for pharma revenues
Rediff.com 2 day(s) ago

Dr Reddy's Laboratories loses Rs 2.16 cr in cyber fraud
Rediff.com 10 Nov 2025

'India Should Move Quickly As Conditions Change'
Rediff.com 02 Jan 2026

Weightloss Drugs Hit 1,000 Crore Mark
Rediff.com 22 Dec 2025

'14+ Anti-Obesity Drugs In The Pipeline'
Rediff.com 13 Dec 2025

Report Card - Dr. Reddy's Laboratories Ltd.

PE Ratios

18.01

EPS (Rs.)

64.14

Sales (Rs. Cr)

4,618.60

Face Value (Rs.)

Net Profit Margin(%)

23.14

Last Bonus

1:1

Last Dividend(%)

800

Return on Average Equity

18.53

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s Q3 Profit Dips 14% to Rs 1,210 Cr

Dr Reddy''s Q3FY26 profit declines 14% to Rs 1,210 crore due to lower US sales. Revenue rises to Rs 8,727 crore. India sales up 19%.

Jan 21, 2026 18:20

Dr Reddy''s & Immutep Ink Cancer Drug Licensing Pact

Dr Reddy''s and Immutep collaborate to develop and commercialize Eftilagimod Alfa (Efti), a cancer medication, outside key markets.

Dec 08, 2025 14:49

Dr Reddy''s Biosimilar Approved in Europe

Dr Reddy''s gets EU nod for AVT03, a biosimilar of Prolia (denosumab) and Xgeva, used to treat osteoporosis and prevent bone complications.

Nov 24, 2025 17:22

Dr Reddy''s Srikakulam Unit Gets USFDA VAI

Dr Reddy''s Srikakulam facility gets Voluntary Action Indicated (VAI) status from USFDA after inspection. Inspection officially closed.

Oct 21, 2025 12:46

Glenmark, Dr Reddy''s Recall Products in US: USFDA

Glenmark and Dr Reddy''s recall products in the US due to manufacturing issues, says USFDA. Recalls include oral contraceptives and muscle relaxants.

Oct 19, 2025 10:20

More News for Dr. Reddy's Laboratories Ltd. »

News for Pharmaceuticals and health care

South India Housing Sales Up 15% | PropTiger Report

Bengaluru, Hyderabad, Chennai housing sales increased 15% last year. PropTiger reports on property market trends in major Indian cities.

Jan 22, 2026 12:03

Optimist Raises $12M Seed Funding

Optimist, a cooling solutions startup, raises $12M led by Accel & Arkam. Plans to scale manufacturing, R&D, and market operations.

Jan 22, 2026 12:01

PhonePe IPO: Walmart, Tiger Global to Offload Stakes

Walmart, Tiger Global, Microsoft Global Finance to offload stakes worth Rs 10,000 cr in PhonePe IPO. IPO is entirely an Offer-for-Sale.

Jan 22, 2026 11:44

PhonePe IPO: Walmart, Tiger Global to Offload Stakes

Walmart, Tiger Global, Microsoft Global Finance to offload stakes worth Rs 10,000 cr in PhonePe IPO. IPO is entirely an Offer-for-Sale.

Jan 22, 2026 11:44

Nasscom Budget Wishlist: Tax Clarity, ESOP Deferment

Nasscom seeks cloud tax clarity, ESOP tax deferment for startups in Union Budget. Also requests carry-forward of losses for all companies.

Jan 22, 2026 11:16

More News »

Top News

South India Housing Sales Up 15% | PropTiger Report

Bengaluru, Hyderabad, Chennai housing sales increased 15% last year. PropTiger reports on property market trends in major Indian cities.

Jan 22, 2026 12:03

Optimist Raises $12M Seed Funding

Optimist, a cooling solutions startup, raises $12M led by Accel & Arkam. Plans to scale manufacturing, R&D, and market operations.

Jan 22, 2026 12:01

PhonePe IPO: Walmart, Tiger Global to Offload Stakes

Walmart, Tiger Global, Microsoft Global Finance to offload stakes worth Rs 10,000 cr in PhonePe IPO. IPO is entirely an Offer-for-Sale.

Jan 22, 2026 11:44

PhonePe IPO: Walmart, Tiger Global to Offload Stakes

Walmart, Tiger Global, Microsoft Global Finance to offload stakes worth Rs 10,000 cr in PhonePe IPO. IPO is entirely an Offer-for-Sale.

Jan 22, 2026 11:44

Nasscom Budget Wishlist: Tax Clarity, ESOP Deferment

Nasscom seeks cloud tax clarity, ESOP tax deferment for startups in Union Budget. Also requests carry-forward of losses for all companies.

Jan 22, 2026 11:16

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist